Emerging evidence demonstrates CTSS promotes NF-κB activation in autoimmune encephalomyelitis, hepatitis, periodontitis, and hyperglycemia-induced endothelial inflammation (19, 29, 84). The gene discussed is NFKB1; the disease is hepatitis A virus infection.